Rolling record / ARQ 63 Concerning · ▲ +2 7-day 3595 events in window / as of 02 Oct 2026
ARQAI Risk Quotient
medicine 49.6 Mixed

Quotient and Acesion Partner on AI Drug Development

This partnership highlights AI's expanding role in pharmaceutical research, which could accelerate drug discovery and improve healthcare outcomes.

This partnership highlights AI’s expanding role in pharmaceutical research, which could accelerate drug discovery and improve healthcare outcomes.

Auto-scored: Event is a low-risk commercial application of AI in medicine with minimal mitigation impact.